Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.4445
-0.0011 (-0.25%)
At close: Nov 11, 2026, 4:00 PM EST
0.4599
+0.0154 (3.46%)
Pre-market: Nov 12, 2026, 8:14 AM EST
Aprea Therapeutics Employees
Aprea Therapeutics had 8 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Aprea Therapeutics the 40,648th largest employer in the world and 6,164th in the United States.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$417
Profits / Employee
-$1,768,104
Market Cap
6.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | 0 | - |
| Dec 31, 2024 | 8 | 1 | 14.29% |
| Dec 31, 2023 | 7 | -2 | -22.22% |
| Dec 31, 2022 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Cerenome | 28 |
| Cardio Diagnostics Holdings | 17 |
| Lantern Pharma | 16 |
| Processa Pharmaceuticals | 12 |
| CNS Pharmaceuticals | 8 |
| XTL Biopharmaceuticals | 5 |
| Cadrenal Therapeutics | 5 |
APRE News
- 2 days ago - Aprea Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 6 days ago - Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference - GlobeNewsWire
- 7 days ago - Aprea Therapeutics reports Q3 EPS (9c), consensus (8c) - TheFly
- 8 days ago - Aprea Therapeutics Announces Third Quarter 2026 Financial Results - GlobeNewsWire
- 8 days ago - Aprea Therapeutics Earnings release: Q3 2026 - Filings
- 8 days ago - Aprea Therapeutics Quarterly report: Q3 2026 - Filings
- 22 days ago - Aprea Therapeutics Transcript: Pre-ESMO Virtual Panel Conference - Transcripts
- 27 days ago - Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology - GlobeNewsWire